Abstract
The content of carbonyl compounds (methylglyoxal and TBA-reactive substances) and components of the glutathione system (activities of glutathione-dependent enzymes, content of oxidized and reduced glutathione) and their interrelationships were studied in men of young reproductive age with type 1 diabetes mellitus at the stages of normo- and microalbuminuria. In patients with normoalbuminuria, the level of methylglyoxal, reduced and oxidized glutathione, and glutathione reductase activity were increased and the content of TBA-reactive substances was decreased. In the group with microalbuminuria, an increase in content of methylglyoxal and activity of glutathione-dependent enzymes relative to the control values were observed; the content of TBA-reactive substances was increased and glutathione reductase activity was decreased relative to the group with normoalbuminuria. In patients with microalbuminuria, a strong correlation between the mean glomerular filtration rate and the blood level of methylglyoxal was revealed.
Key Words: carbonyl compounds, glutathione-dependent enzymes, type 1 diabetes mellitus, microalbuminuria, men
Footnotes
Translated from Byulleten’ Eksperimental’noi Biologii i Meditsiny, Vol. 171, No. 5, pp. 562-566, May, 2021
References
- 1.Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative Stress: Pathogenetic Role in Diabetes Mellitus and Its Complications and Therapeutic Approaches to Correction. Bull. Exp. Biol. Med. 2021;171(2):179–189. doi: 10.1007/s10517-021-05191-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Dzugkoev SG, Kaloeva MB, Dzugkoeva FS. Effect of combination therapy with coenzyme Q10 on functional and metabolic parameters in patients with type 1 diabetes mellitus. Bull. Exp. Biol. Med. 2012;152(3):364–366. doi: 10.1007/s10517-012-1529-7. [DOI] [PubMed] [Google Scholar]
- 3.Kamyshnikov VS. Clinical Biochemical Laboratory Diagnostics: Handbook. Moscow, 2009. Russian.
- 4.Chistyakova OV, Sukhov IB, Shpakov AO. The role of oxidative stress and antioxidant enzymes in the development of diabetes mellitus. Ross. Fiziol. Zh. 2017;103(9):987–1003. [Google Scholar]
- 5.Forbes JM, Fotheringham AK. Vascular complications in diabetes: old messages, new thought. Diabetologia. 2017;60(11):2129–2138. doi: 10.1007/s00125-017-4360-x. [DOI] [PubMed] [Google Scholar]
- 6.Goh SY, Cooper ME. The role of advanced glycation end products in progression and complications of diabetes. J. Clin. Endocrinol. Metab. 2008;93(4):1143–1152. doi: 10.1210/jc.2007-1817. [DOI] [PubMed] [Google Scholar]
- 7.Kolesnikova LI, Shemyakina NA, Namokonov EV, Darenskaya MA, Grebenkina LA, Kolesnikov SI. Some parameters of carbonyl and oxidative stress in patients with type 2 diabetes mellitus and macroangiopathy of the lower extremities. Diabetes Technol. Therapeutics. 2019;21(Suppl. 1):46. [Google Scholar]
- 8.Kolesnikova LI, Vlasov BY, Kolesnikov SI, Darenskaya MA, Grebenkina LA, Semenova NV, Vanteeva OA. Intensity of oxidative stress in Mongoloid and Caucasian patients with type 1 diabetes mellitus. Bull. Exp. Biol. Med. 2016;161(6):767–769. doi: 10.1007/s10517-016-3505-0. [DOI] [PubMed] [Google Scholar]
- 9.Krolewski AS. Progressive renal decline: the new paradigm of diabetic nephropathy in type 1 diabetes. Diabetes Care. 2015;38(6):954–962. doi: 10.2337/dc15-0184. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Lankin VZ, Tikhaze AK, Konovalova GG, Odinokova OA, Doroshchuk NA, Chazova IE. Oxidative and carbonyl stress as a factors of the modification of proteins and DNA destruction in diabetes. Ter. Arkh. 2018;90(10):46–50. doi: 10.26442/terarkh2018901046-50. [DOI] [PubMed] [Google Scholar]
- 11.Papadopoulou-Marketou N, Chrousos GP, Kanaka-Gantenbein C. Diabetic nephropathy in type 1 diabetes: a review of early natural history, pathogenesis, and diagnosis. Diabetes Metab. Res. Rev. 2017;33(2). doi: 10.1002/dmrr.2841 [DOI] [PubMed]
- 12.Rabbani N, Thornalley PJ. The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy. Diabetes. 2014;63(1):50–52. doi: 10.2337/db13-1606. [DOI] [PubMed] [Google Scholar]
- 13.Ramachandra Bhat L, Vedantham S, Krishnan UM, Rayappan JBB. Methylglyoxal — an emerging biomarker for diabetes mellitus diagnosis and its detection methods. Biosens. Bioelectron. 2019;133:107–124. doi: 10.1016/j.bios.2019.03.010. [DOI] [PubMed] [Google Scholar]
- 14.Selvin E, Juraschek SP. Diabetes epidemiology in the COVID-19 pandemic. Diabetes Care. 2020;43(8):1690–1694. doi: 10.2337/dc20-1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15.Sifuentes-Franco S, Padilla-Tejeda DE, Carrillo-Ibarra S, Miranda-Díaz AG. Oxidative stress, apoptosis, and mitochondrial function in diabetic nephropathy. Int. J. Endocrinol. 2018;2018:1875870. doi: 10.1155/2018/1875870. [DOI] [PMC free article] [PubMed] [Google Scholar]